Private company

MINERVA SURGICAL INC

American surgical and medical instruments and apparatus company1

In its 2023 annual report the company says: “We are a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. We have established a broad product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of abnormal uterine bleeding (AUB) in most uterine anatomies.”45 It is headquartered in Santa Clara, California.1

Last updated Oct 20, 2026.

Overview

  • IndustrySurgical & Medical Instruments & Apparatus1
  • HeadquartersSanta Clara, California1
  • Incorporated inDE2
  • Business address4255 Burton Drive, Santa Clara, Ca 950542
  • Filer category, Emerging growth company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

54.2%Gross margin3
-61.4%Operating margin3
-67.8%Net margin3
-3.5%Revenue growth, 20223
-198.5%Return on equity3
2.18×Debt to equity3
-$35.6MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Cost of revenue46¢$23.1M
  • Research and development11¢$5.4M
  • Other costs37¢$18.6M
  • Interest6¢$3.2M
  • Income tax0¢$11.0K

Out of $50.3M in revenue.3 The company lost money this year.

Financial statements

Revenue43$50.3M in 2022+33% since 2020
0$20.0M$40.0M$60.0M2020: $37.8M$37.8M20202021: $52.1M$52.1M2021+38%2022: $50.3M$50.3M2022−3%
Gross profit43$27.2M in 2022+42% since 2020
0$10.0M$20.0M$30.0M$40.0M2020: $19.1M$19.1M20202021: $30.5M$30.5M2021+60%2022: $27.2M$27.2M2022−11%
Operating income43-$30.9M in 2022+101% since 2020
-$40.0M-$30.0M-$20.0M-$10.0M02020: -$15.4M-$15.4M20202021: -$29.1M-$29.1M2021+89%2022: -$30.9M-$30.9M2022+6%
Net income43-$34.1M in 2022+87% since 2020
-$40.0M-$30.0M-$20.0M-$10.0M02020: -$18.3M-$18.3M20202021: -$21.5M-$21.5M2021+18%2022: -$34.1M-$34.1M2022+59%
Fiscal year2019202020212022
Revenue$37.8M4$52.1M3$50.3M3
Cost of revenue$18.6M4$21.6M3$23.1M3
Gross profit$19.1M4$30.5M3$27.2M3
Research and development$3.3M4$5.3M3$5.4M3
Operating expenses$59.7M3$58.1M3
Operating income-$15.4M4-$29.1M3-$30.9M3
Interest$12.1M4$11.7M3$3.2M3
Income before tax-$21.5M3-$34.1M3
Income tax-$132.0K4$9.0K3$11.0K3
Net income-$18.3M4-$21.5M3-$34.1M3
Earnings per share-$3.063-$1.183
Earnings per share (diluted)-$3.063-$1.183

Compare MINERVA SURGICAL INC with another company

Corporate structure

MINERVA SURGICAL INC sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of MINERVA SURGICAL INC

  • Accelmed Partners II L.P. Filed SC 13D/A on MINERVA SURGICAL INC, latest Sep 28, 2023 (3 filings since Feb 9, 2023)
  • NEW ENTERPRISE ASSOCIATES 13 LP Filed SC 13D/A on MINERVA SURGICAL INC, latest Jul 7, 2023 (4 filings since Nov 17, 2021)
  • AWM Investment Company, Inc. Filed SC 13G/A on MINERVA SURGICAL INC, latest May 10, 2023 (2 filings since Feb 14, 2023)
  • CVF, LLC Filed SC 13G/A on MINERVA SURGICAL INC, latest Feb 10, 2023 (2 filings since Feb 10, 2022)
  • Novo Holdings A/S Filed SC 13G/A on MINERVA SURGICAL INC, latest Nov 3, 2022 (2 filings since Oct 27, 2021)
  • Versant Venture Capital IV, L.P. Filed SC 13G on MINERVA SURGICAL INC, latest Feb 11, 2022
  • VIVO VENTURES VII, LLC Filed SC 13G on MINERVA SURGICAL INC, latest Nov 1, 2021
  • MINERVA SURGICAL INC Santa Clara, California

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What MINERVA SURGICAL INC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$15.5M3 Dec 31, 2022$13.9M3 Dec 31, 2021+11.2%
Accumulated depreciation$10.4M3 Dec 31, 2022$9.3M3 Dec 31, 2021+11.9%
Property and equipment, net$5.0M3 Dec 31, 2022$4.6M3 Dec 31, 2021+9.8%
Operating-lease assets (leased space)$270.0K3 Dec 31, 2022

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$6.9M3 Dec 31, 2022$40.6M3 Dec 31, 2021−82.9%

Intangibles and goodwill

ItemLatestA year beforeChange
Finite-lived intangibles, gross$48.3M3 Dec 31, 2022$48.3M3 Dec 31, 20210%
Accumulated amortization$21.5M3 Dec 31, 2022$13.3M3 Dec 31, 2021+61.5%
Finite-lived intangibles, net$26.8M3 Dec 31, 2022$35.0M3 Dec 31, 2021−23.4%

Inventory

ItemLatestA year beforeChange
Inventory, total$16.9M3 Dec 31, 2022$15.7M3 Dec 31, 2021+7.4%
Finished goods$7.1M3 Dec 31, 2022$9.5M3 Dec 31, 2021−24.8%

Leadership

Who has led MINERVA SURGICAL INC, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. David M. Clapper2021–2022
  2. Todd Usen2023

President

  1. David M. Clapper2021–2022

Chief financial officer

  1. Joel R. Jung2021–2022

Chief operating officer

  1. Dominique J. Filloux2021–2022
2025
Board members and other officers (11)

Timeline

  1. Dec 15, 20238-K Listing notice or transfer; Regulation FD disclosure21
  2. Nov 13, 20238-K Results of operations22
  3. Nov 2, 20238-K Other events23
  4. Oct 13, 20238-K Executive or director change24
  5. Sep 29, 20238-K Change to shareholders' rights; Bylaws or fiscal year changed25
  6. Sep 28, 20238-K Entered a material agreement; Unregistered sale of shares; Regulation FD disclosure26
  7. Aug 2, 20238-K Results of operations27
  8. Jul 7, 20238-K Executive or director change; Other events28
  9. May 2, 20238-K Results of operations29
  10. Mar 21, 20238-K Results of operations; Regulation FD disclosure30
  11. Mar 14, 20238-K Regulation FD disclosure31
  12. Mar 7, 20238-K Executive or director change32
  13. Feb 8, 2023New chief executive Todd Usen becomes CEO8
  14. Oct 21, 2021New chief executive David M. Clapper becomes CEO9

Calendar

When it reported results

  1. Nov 13, 2023Reported quarterly or annual results22
  2. Aug 2, 2023Reported quarterly or annual results27
  3. May 2, 2023Reported quarterly or annual results29
  4. Mar 21, 2023Reported quarterly or annual results30
  5. Nov 16, 2022Reported quarterly or annual results33
  6. Aug 9, 2022Reported quarterly or annual results34
  7. May 11, 2022Reported quarterly or annual results35
  8. Mar 22, 2022Reported quarterly or annual results36

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

120 filings to the SEC since October 2021: 3 annual reports, 7 quarterly reports, 30 major events, 44 insider forms, 15 large holders, 21 other. The latest 20:

  1. Jan 4, 202415-12G EDGAR
  2. Dec 26, 202325 EDGAR
  3. Dec 26, 2023S-8 POS EDGAR
  4. Dec 15, 20238-K EDGAR
  5. Nov 13, 202310-Q EDGAR
  6. Nov 13, 20238-K EDGAR
  7. Nov 2, 2023SC 13E3/A EDGAR
  8. Nov 2, 20238-K EDGAR
  9. Oct 13, 20238-K EDGAR
  10. Sep 29, 20238-K EDGAR
  11. Sep 28, 2023SC 13E3 EDGAR
  12. Sep 28, 2023SC 13D/A EDGAR
  13. Sep 28, 20238-K EDGAR
  14. Aug 3, 202310-Q EDGAR
  15. Aug 2, 20238-K EDGAR
  16. Jul 7, 2023SC 13D/A NEW ENTERPRISE ASSOCIATES 13, LP (MINERVA SURGICAL, INC) - SCHEDULE 13D/A(#3E) EDGAR
  17. Jul 7, 20238-K EDGAR
  18. Jul 6, 2023SC 13D/A EDGAR
  19. May 10, 2023SC 13G/A UTRS 13G/A EDGAR
  20. May 3, 202310-Q EDGAR

The 120 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

4 open-market trades by officers, directors and large owners since October 2021: 4 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Feb 9, 2023NEA Partners 13, Limited Partnership10% ownerBuy24,437,927$0.20$4.9MForm 4
Dec 13, 2021Clapper David MPresident and CEOBuy25,000$4.94$123.5KForm 4
Oct 26, 2021NEW ENTERPRISE ASSOCIATES 13 LP10% ownerBuy1,300,000$12.00$15.6MForm 4
Oct 26, 2021Novo Holdings A/S10% ownerBuy580,000$12.00$7.0MForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How MINERVA SURGICAL INC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARMINERVA SURGICAL INC1
  • CIK0001452965
  • Employer ID (EIN)26-34229061
  • Filer status<br>emerging growth company1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)3841 Surgical & Medical Instruments & Apparatus1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address4255 Burton Drive, Santa Clara, CA 950541
  • Phone(855) 646-78741
  • Shares outstanding8,878,582 as of Nov 2, 20237
  • Public float$31.9M as of Jun 30, 202244
  • On EDGAR sinceDec 19, 20081
  • Filings141 in all: 8-K (28), 4 (21), 3 (17), D (14), 10-Q (7), SC 13D/A (5), SC 13G (5), 4/A (4)1
    All 36 form types

    DEFA14A (3), SC 13G/A (3), SEC STAFF LETTER (3), 10-K (2), 3/A (2), 8-K/A (2), CORRESP (2), DEF 14A (2), SC 13D (2), 10-K/A (1), 15-12G (1), 25 (1), 424B4 (1), 8-A12B (1), CERT (1), DRS (1), DRS/A (1), DRSLTR (1), EFFECT (1), PRE 14A (1), REGDEX (1), S-1 (1), S-1/A (1), S-8 (1), S-8 POS (1), SC 13E3 (1), SC 13E3/A (1), UPLOAD (1)

  • Latest filingsAnnual report (10-K) Mar 22, 2023
    Quarterly report (10-Q) Nov 13, 2023
    Proxy statement (DEF 14A) Jan 23, 2023
    Latest 8-K (8-K) Dec 15, 2023

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
    SEC EDGAROther events
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45